The Next Era in Non-Factor Therapy for Hemophilia

Time

7:20 am–7:35 am Breakfast & Registration

7:35 am–8:50 am Symposium Presentation

Overview

Hemophilia care continues to evolve with the emergence of new therapies that offer transformative alternatives to traditional treatment approaches. This activity focuses on the latest clinical evidence surrounding FVIIIa mimetic therapies, including mechanisms of action, pharmacokinetics, dosing strategies, and their practical implications in patient care. Data from pivotal trials will be examined, along with guidance for incorporating these agents into everyday clinical practice. Through interactive, case-based scenarios, learners will develop a deeper understanding of patient selection, treatment sequencing, and individualized management strategies equipping clinicians with the tools needed to optimize outcomes in hemophilia care.

Target Audience

This educational activity is intended for pediatric and adult hematologists, hematologists/oncologists, hematology and hematology/oncology APPs, and other HCPs involved in the management of people living with hemophilia

Educational Objectives

• Describe structural and pharmacokinetic (PK)/pharmacodynamic (PD) distinctions, and the related impact on dosing, between available and emerging FVIIIa mimetics

• Assess efficacy and safety evidence on emerging FVIIIa mimetics as prophylaxis across varying hemophilia patient populations

• Develop treatment plans with people living with hemophilia A (PLwHA) that incorporate FVIIIa mimetic therapies, considering initiation, switching, and monitoring protocols

• Recognize strategies that align with shared decision making (SDM) principles to engage PLwH in individualized goal setting, treatment selection, and long-term adherence and compliance

Commercial Support

This activity is supported by an educational grant from Novo Nordisk.

Provider

This program is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.

CME/CE Information

Joint Accreditation Statement

Credit provided by AKH Inc., Advancing Knowledge in Healthcare.

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Ph*rm*cy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

Credit Types Offered

Physicians

AKH Inc., Advancing Knowledge in Healthcare designates this live material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

Credit being awarded: 1.25 ANCC contact hours.

Pharmacists

AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.25 contact hours.

Criteria for Success

To obtain credit, you must participate in the entire activity and submit the post-test and evaluation. You must receive a 70% or higher on the post-test to successfully complete this activity. No partial credit will be awarded. The Certificate of Completion is immediately available for download after submitting your evaluation. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at [email protected].

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the U.S. Food and Drug Administration (FDA). Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional and, therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants’ misunderstanding of the content. If you would like to opt out from future communications from AKH Inc., please send an email to [email protected] with your information with “Opt Out” in the subject line.